EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System

Toru Ogura iD, Chihiro Shiraishi iD, Aiko Urawa iD

Clinical Transplantation and Research · 30.06.2025 · 39 (2) · 131-141

DOI: 10.4285/ctr.24.0049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation and Research, online erschienen am 15.04.2025. Verfasst von Toru Ogura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Support Center, Mie University Hospital, Tsu, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CyclosporineGraft vs host diseaseHematopoietic stem cell transplantationPersonalized medicinePharmacovigilance

Autor:innen und Institutionen

  • Clinical Research Support Center, Mie University Hospital, Tsu, Japan.
  • Department of Pharmacy, Mie University Hospital, Tsu, Japan.
  • Organ Transplantation Center, Mie University Hospital, Tsu, Japan.

ORCID-Profile: Toru Ogura, Chihiro Shiraishi, Aiko Urawa

Zitieren

APA

Ogura, T., Shiraishi, C., & Urawa, A. (2025). Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System. Clinical Transplantation and Research, 39(2), 131-141. https://doi.org/10.4285/ctr.24.0049

Vancouver

Ogura T, Shiraishi C, Urawa A. Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System. Clinical Transplantation and Research. 2025;39(2):131-141. doi:10.4285/ctr.24.0049

BibTeX
@article{Ogura2025,
  author = {Ogura, Toru and Shiraishi, Chihiro and Urawa, Aiko},
  title = {Comparing drug combinations for graft-versus-host disease prophylaxis using the U.S. Food and Drug Administration Adverse Event Reporting System},
  journal = {Clinical Transplantation and Research},
  year = {2025},
  volume = {39},
  number = {2},
  pages = {131--141},
  doi = {10.4285/ctr.24.0049}
}
Kostenlos starten →